ORMP icon

Oramed Pharmaceuticals
ORMP

Overview Fund Trends Analyst Outlook Journalist POV

56 hedge funds and large institutions have $18.6M invested in Oramed Pharmaceuticals in 2024 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 14 increasing their positions, 17 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

more funds holding in top 10

Funds holding in top 10: →

more first-time investments, than exits

New positions opened: | Existing positions closed:

more capital invested

Capital invested by funds: $ → $

more ownership

Funds ownership: →

2% more funds holding

Funds holding: 55 → 56 (+1)

17% less call options, than puts

Call options by funds: $44K | Put options by funds: $53K

18% less repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 17

Holders
56
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$44K
Puts
$53K
Net Calls
Net Calls Change

Top Buyers

1
+$1.11M
2
+$205K
3
+$197K
4
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$170K
5
Citadel Advisors
Citadel Advisors
Florida
+$124K

Top Sellers

1
-$226K
2
-$105K
3
-$75.8K
4
Squarepoint
Squarepoint
New York
-$70K
5
XT
XTX Topco
Cayman Islands
-$60.3K
Name Holding Trade Value Shares
Change 		Change in
Stake
51
$733
52
$530
53
$484
54
$242
55
$242
56
$5
57
–
58
–
59
–
60
–
61
–
62
–
63
–
64
–
1 2
3